Search results

Found 51 pages
AUTHOR: Hugh Gosling

Results per page

10 20 50 100

Sort by

Relevance Date

1 Jan 2016:

The price is right - PharmaTimes Magazine January 2016

Drug pricing was put under more scrutiny than ever last year after US company Turing Pharmaceuticals bought the 62-year old drug daraprim and raised the price from $13.50 to $750 in the country, resulting in international backlash. - Magazine

by Hugh Gosling

https://www.pharmatimes.com/magazine/2016/january_2016/the_price_is_right

7 Apr 2016:

Global threat of diabetes highlighted by WHO

The number of people with diabetes has nearly quadrupled since 1980, with an estimated 422 million people living with the condition across the world in 2014, says a WHO report.  - News - PharmaTimes

by Hugh Gosling

https://www.pharmatimes.com/news/global_threat_of_diabetes_highlighted_by_who_1020514

1 Jan 2016:

Trust fund? - PharmaTimes Magazine January 2016

The Cancer Drugs Fund (CDF) began to crack under increasing pressure last year. - Magazine Article - PharmaTimes

by Hugh Gosling

https://www.pharmatimes.com/magazine/2016/january_2016/trust_fund

8 Apr 2016:

EU approval for Revolade for children with rare blood disorder

The European Commission has approved Novartis’ Revolade (eltrombopag) as a first-in-class therapy for children aged one and over with chronic idiopathic thrombocytopenic purpura (ITP) that have not responded to other treatments. - News -

by Hugh Gosling

https://www.pharmatimes.com/news/eu_approval_for_revolade_for_children_with_rare_blood_disorder_1020508

25 Jul 2016:

NICE approves Servier’s Lonsurf as third-line cancer therapy

The National Institute for Health and Care Excellence has recommended trifluridine/tipiracil as an option for treating metastatic colorectal cancer. - News - PharmaTimes

by Hugh Gosling

https://www.pharmatimes.com/news/nice_approves_serviers_lonsurf_as_third-line_cancer_therapy_1080661

1 Apr 2016:

Outside the box - PharmaTimes Magazine April 2016

Going 'beyond the pill' is a major trend in pharma today, with companies seeking innovative approaches to engaging patients and driving growth. While much of the innovation comes from the digital space, there are other ways to create value for

by Hugh Gosling

https://www.pharmatimes.com/magazine/2016/april_2016/outside_the_box

1 Mar 2016:

Popcorn and patients - PharmaTimes Magazine March 2016

Pharma is harnessing the power of fictional films to raise disease awareness and tell patient stories - Magazine Article - PharmaTimes

by Hugh Gosling

https://www.pharmatimes.com/magazine/2016/march_2016/popcorn_and_patients

22 Dec 2015:

Pharma to advance £200m to UK government to fund 2016 medicines bill

A new financial agreement with the UK government will see pharmaceutical companies bring forward payments of around £200 million to help pay for NHS patients’ medicines in 2016. - News - PharmaTimes

by Hugh Gosling

https://www.pharmatimes.com/news/pharma_to_advance_200m_to_uk_government_to_fund_2016_medicines_bill_972305

21 Dec 2015:

Lilly's Portrazza one step closer to approval in Europe

Patients with a devastating type of lung cancer have fresh hope after the EMA’s Committee for Medicinal Products for Human Use (CHMP) issued a positive opinion for Eli Lily’s Portrazza (necitumumab). - News - PharmaTimes

by Hugh Gosling

https://www.pharmatimes.com/news/lillys_portrazza_one_step_closer_to_approval_in_europe_972301

27 May 2016:

SmartPeople: Growth spurt - PharmaTimes Magazine June 2016

After spending most of his career in the US, Takeda UK managing director Adam Zaeske arrived on our shores last year intent on transforming the company into an agile speciality business - Magazine Article - PharmaTimes

by Hugh Gosling

https://www.pharmatimes.com/magazine/2016/june_2016/growth_spurt